Kelley R F, Costas K E, O'Connell M P, Lazarus R A
Department of Protein Engineering, Genentech, Inc., South San Francisco, California 94080, USA.
Biochemistry. 1995 Aug 22;34(33):10383-92. doi: 10.1021/bi00033a009.
Surface plasmon resonance (SPR) measurements on a BIAcore instrument have been used to measure the effects of mutations in human tissue factor (TF), the initiator of blood coagulation, on the kinetics and affinity of binding to human FVIIa. TF mutant proteins were produced in soluble form by expression of the extracellular domain (sTF) in Escherichia coli followed by immunoaffinity purification. Mutants were designed and analyzed on the basis of the structure of sTF recently determined by X-ray crystallography [Muller et al. (1994) Biochemistry 33, 10864-10870]. Wild-type sTF binding to immobilized FVIIa has k(on) = 3.4 +/- 0.8 x 10(5) M-1 s-1 and k(off) = 2.1 +/- 0.1 x 10(-3) s-1 with a calculated KD of 6.3 +/- 1.2 nM and delta G of -11.2 +/- 0.1 kcal mol-1. Calorimetric measurements indicate that binding occurs with a favorable delta H of -32 kcal mol-1, an unfavorable delta S of -70 cal K-1 mol-1, and a delta Cp of -730 cal K mol-1. The value of delta Cp is consistent with burial of a large nonpolar surface area upon binding. Five residues on TF, Lys20, Trp45, Asp58, Tyr94, and Phe140, make a large contribution (delta delta G = 1-2.5 kcal mol-1) to FVIIa binding, a set of 17 mutations result in modest decreases in affinity (delta delta G = 0.3-1 kcal mol-1), and 40 mutations have delta delta G smaller than the experimental uncertainty (+/- 0.3 kcal mol-1). Mutations at four sites result in small (0.3-0.5 kcal mol-1) increases in affinity. Decreases in affinity result primarily from increased rates of dissociation. These data define a putative FVIIa binding site on one face of the TF structure with most of the contacts contributed by the N-terminal fibronectin type III domain. The critical binding residues are found on beta-strands. An additional set of residues located on the surface of the C-terminal fibronectin type III domain opposite the FVIIa binding site have a role in the procoagulant activity of sTF but are not involved in FVIIa binding.
在BIAcore仪器上进行的表面等离子体共振(SPR)测量已用于测定人类组织因子(TF)(血液凝固的启动因子)中的突变对与人类FVIIa结合的动力学和亲和力的影响。TF突变蛋白通过在大肠杆菌中表达细胞外结构域(sTF)然后进行免疫亲和纯化以可溶形式产生。根据最近通过X射线晶体学确定的sTF结构设计并分析了突变体[Muller等人(1994年)《生物化学》33卷,10864 - 10870页]。野生型sTF与固定化FVIIa的结合,其结合速率常数k(on) = 3.4 +/- 0.8 x 10(5) M-1 s-1,解离速率常数k(off) = 2.1 +/- 0.1 x 10(-3) s-1,计算得到的解离常数KD为6.3 +/- 1.2 nM,自由能变化delta G为 -11.2 +/- 0.1 kcal mol-1。量热测量表明,结合时的焓变delta H为 -32 kcal mol-1,熵变delta S为 -70 cal K-1 mol-1,热容变化delta Cp为 -730 cal K mol-1。delta Cp的值与结合时大的非极性表面积的埋藏一致。TF上的五个残基,即赖氨酸20、色氨酸45、天冬氨酸58、酪氨酸94和苯丙氨酸140,对FVIIa结合有很大贡献(delta delta G = 1 - 2.5 kcal mol-1),一组17个突变导致亲和力适度降低(delta delta G = 0.3 - 1 kcal mol-1),40个突变的delta delta G小于实验不确定度(+/- 0.3 kcal mol-1)。四个位点的突变导致亲和力小幅增加(0.3 - 0.5 kcal mol-1)。亲和力降低主要是由于解离速率增加。这些数据在TF结构的一个面上定义了一个假定的FVIIa结合位点,其中大部分接触由N端纤连蛋白III型结构域贡献。关键的结合残基位于β链上。位于与FVIIa结合位点相对的C端纤连蛋白III型结构域表面的另一组残基在sTF的促凝血活性中起作用,但不参与FVIIa结合。